Literature DB >> 29588306

Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015.

Monica L Kasting1,2, Anna R Giuliano2,3, Richard R Reich4, Richard G Roetzheim1,5, David R Nelson6, Elizabeth Shenkman7,8, Susan T Vadaparampil9,2.   

Abstract

Background: Rates of hepatitis C virus (HCV) infection are markedly higher for baby boomers compared with other birth cohorts, and they are now recommended for universal one-time screening. This study examines HCV screening rates and predictors for four birth cohorts [born <1945, born 1945-1965 (baby boomers), born 1966-1985, and born >1985] of a nationally representative sample over time.
Methods: We used data from the 2013-2015 National Health Interview Surveys, an annual weighted survey of the U.S. civilian noninstitutionalized population. We assessed HCV screening prevalence stratified birth cohort with bivariate and multivariable logistic regression analyses.
Results: There were 15,100 participants born <1945, 28,725 baby boomers, 28,089 born 1966-1985, and 13,296 born >1985 in the final analytic sample. Screening was 11.5%-12.8% for baby boomers. The second youngest birth cohort was similar to baby boomers (13.7%-14.9%), whereas the older birth cohort was screened less. After excluding participants who typically have higher rates of HCV screening than the general population, we developed a multivariable model of the general population. In the final model for baby boomers the odds of HCV screening increased significantly with each subsequent year (OR=1.20; 95% CI=1.05-1.38 and OR=1.31; 95% CI=1.13-1.52). HCV screening was also significantly associated with age, gender, and race/ethnicity in baby boomers.Conclusions: While HCV screening is increasing over time, these increases are minimal and there is substantial room for improvement.Impact: Future research should develop interventions to increase HCV screening with special focus on groups demonstrating significantly lower screening rates, such as Hispanics and females. Cancer Epidemiol Biomarkers Prev; 27(4); 503-13. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 29588306      PMCID: PMC5884715          DOI: 10.1158/1055-9965.EPI-17-0855

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  35 in total

1.  A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System.

Authors:  David E Nelson; Eve Powell-Griner; Machell Town; Mary Grace Kovar
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

2.  High rates of uninsured among HCV-positive individuals.

Authors:  Janus P Ong; Rochelle Collantes; Angela Pitts; Lisa Martin; Michael Sheridan; Zobair M Younossi
Journal:  J Clin Gastroenterol       Date:  2005-10       Impact factor: 3.062

3.  Recent Hepatitis C Virus Testing Patterns Among Baby Boomers.

Authors:  Ahmedin Jemal; Stacey A Fedewa
Journal:  Am J Prev Med       Date:  2017-03-08       Impact factor: 5.043

4.  Trends in colorectal cancer test use among vulnerable populations in the United States.

Authors:  Carrie N Klabunde; Kathleen A Cronin; Nancy Breen; William R Waldron; Anita H Ambs; Marion R Nadel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-08       Impact factor: 4.254

Review 5.  Impact of hepatitis C virus eradication on hepatocellular carcinogenesis.

Authors:  Darrick K Li; Raymond T Chung
Journal:  Cancer       Date:  2015-06-16       Impact factor: 6.860

Review 6.  Hepatitis C screening.

Authors:  Shobha N Joshi
Journal:  Ochsner J       Date:  2014

7.  Hepatitis C seroprevalence among prison inmates since 2001: still high but declining.

Authors:  Aiden K Varan; Daniel W Mercer; Matthew S Stein; Anne C Spaulding
Journal:  Public Health Rep       Date:  2014 Mar-Apr       Impact factor: 2.792

8.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-16

9.  Hepatitis C virus-infected patients report communication problems with physicians.

Authors:  Susan Zickmund; Stephen L Hillis; Mitchell J Barnett; Laura Ippolito; Douglas R LaBrecque
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

10.  Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease.

Authors:  R Befrits; M Hedman; L Blomquist; T Allander; L Grillner; N Kinnman; C Rubio; R Hultcrantz
Journal:  Scand J Gastroenterol       Date:  1995-11       Impact factor: 2.423

View more
  21 in total

1.  The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.

Authors:  Andrew D Schreiner; John Bian; Jingwen Zhang; Z Merle Haulsee; Justin Marsden; Valerie Durkalski-Mauldin; Patrick D Mauldin; William P Moran; Don C Rockey
Journal:  Am J Med       Date:  2019-07-29       Impact factor: 4.965

2.  The HCV Treatment Cascade: Race Is a Factor to Consider.

Authors:  Maya Balakrishnan; Fasiha Kanwal
Journal:  J Gen Intern Med       Date:  2019-10       Impact factor: 5.128

3.  Improving Hepatitis C Screening in the Baby Boomer Birth Cohort in Rural South Dakota: A Medical Student HQIP Project.

Authors:  Garrett Weber; Emmett Chappelle; Valerie J Bares
Journal:  S D Med       Date:  2020-01

Review 4.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Authors:  Anne F Peery; Seth D Crockett; Caitlin C Murphy; Jennifer L Lund; Evan S Dellon; J Lucas Williams; Elizabeth T Jensen; Nicholas J Shaheen; Alfred S Barritt; Sarah R Lieber; Bharati Kochar; Edward L Barnes; Y Claire Fan; Virginia Pate; Joseph Galanko; Todd H Baron; Robert S Sandler
Journal:  Gastroenterology       Date:  2018-10-10       Impact factor: 22.682

Review 5.  Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

Authors:  Andrew M Moon; Amit G Singal; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2019-08-08       Impact factor: 11.382

6.  Hepatitis C virus screening trends: A 2016 update of the National Health Interview Survey.

Authors:  Monica L Kasting; Anna R Giuliano; Richard R Reich; Richard G Roetzheim; Linh M Duong; Emmanuel Thomas; David R Nelson; Elizabeth Shenkman; Susan T Vadaparampil
Journal:  Cancer Epidemiol       Date:  2019-04-03       Impact factor: 2.984

7.  Universal HCV Screening of Baby Boomers is Feasible, but It is Difficult.

Authors:  Paul J Thuluvath; Joshua Trowell; Talan Zhang; Joseph Alukal; George Lowe
Journal:  J Clin Exp Hepatol       Date:  2021-02-25

8.  HCV testing: Order and completion rates among baby boomers obtaining care from seven health systems in Florida, 2015-2017.

Authors:  Susan T Vadaparampil; Lindsay N Fuzzell; Julie Rathwell; Richard R Reich; Elizabeth Shenkman; David R Nelson; Erin Kobetz; Patricia D Jones; Richard Roetzheim; Anna R Giuliano
Journal:  Prev Med       Date:  2020-07-25       Impact factor: 4.018

9.  Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals.

Authors:  Julia L Marcus; Michael J Silverberg; Jennifer O Lam; Leo B Hurley; Jennifer B Lai; Varun Saxena; Suk Seo; Scott Chamberland; Charles P Quesenberry; Jamila H Champsi; Joanna Ready; Elizabeth Y Chiao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-28       Impact factor: 4.090

10.  Economically Efficient Hepatitis C Virus Treatment Prioritization Improves Health Outcomes.

Authors:  Lauren E Cipriano; Shan Liu; Kaspar S Shahzada; Mark Holodniy; Jeremy D Goldhaber-Fiebert
Journal:  Med Decis Making       Date:  2018-08-22       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.